Clinical Trial Update: A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

Phase 2 dose-escalation trial evaluating the immunogenicity and safety of the Rotavin-M1 rotavirus vaccine in healthy infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Rotavirus Gastroenteritis

Drugs mentioned

• Rotavin-M1 (Rotavirus vaccine, live attenuated)

Snippet

Sponsor: National Institute of Hygiene and Epidemiology, Vietnam | Conditions: Diarrhea, Fever | Phase 2 | Status: COMPLETED